Associated Papers
Using Co-segregation and Loss of Heterozygosity Analysis to Define the Pathogenicity of Unclassified Variants in Hereditary Breast Cancer Patients.
Grasel RS et al.
Frontiers in Oncology, 2020
33134171 (PubMed )
Supplement: Data_Sheet_1.docx
Select a paper to view details